ArticleEuropean journal of rheumatology2021

Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases.

Cosimo Bruni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.